Back to results

Massachusetts Institute of Technology

Globalization of biopharmaceutical manufacturing

Abstract

dc:description.abstract

The biomanufacturing industry is changing due to increasing globalization. However, it is changing differently from other high tech industries like software/ semiconductor/ automobiles. In this study we use global biomanufacturing investment data, industry survey data as well as interviews with members of industry and academia to understand the extent of microbial biomanufacturing activity (total volume, number of facilities, type of facilities) and nature of biomanufacturing activity (complexity of products and processes across both mammalian and microbial production) in different regions of the world today. The study shows that traditional centers of expertise in US and EU still house most of the worlds biomanufacturing capacity. The facilities in US and EU perform a larger number of operations within their facilities and also more technically complex operations than facilities in Asia. US facilities support the most complex products (median unit operations =13) and processes (cell culture, purification) and maximum average products per facility(12.2). Asian facilities support simpler products (median unit operations =7), simpler processes (fermentation, fill/finish) and fewer products per facility on average (3.25). These results support the idea that managing technical complexity is one of the biggest challenges in biomanufacturing today and it can determine where a biologic can be manufactured. While economic forces push manufacturing of biologics to low cost locations, the need to develop expertise may prevent manufacturing from scattering across the world. Instead, there may be a more guided flow to locations with an expertise in certain types of products and processes.

Degree

thesis:*
Department dc:contributor.department
Massachusetts Institute of Technology. Engineering Systems Division.
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2011

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Pande, Rachna
Advisor dc:contributor.advisor
  • Anthony J Sinskey and Scott Stern.

Subjects

dc:subject × 2

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/68449
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/68449

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Pande, Rachna. Globalization of biopharmaceutical manufacturing. Massachusetts Institute of Technology, 2011. http://hdl.handle.net/1721.1/68449